Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: Evidence from animal models
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Adaptive responding to threatening stressors is of fundamental importance for survival. Dysfunctional hyperactivation of corticotropin releasing factor type-1 (CRF1) receptors in stress response system pathways is linked to stress-related psychopathology and CRF1 receptor antagonists (CRAs) have been proposed as novel therapeutic agents. CRA effects in diverse animal models of stress that detect anxiolytics and/or antidepressants are reviewed, with the goal of evaluating their potential therapeutic utility in depression, anxiety, and other stress-related disorders. CRAs have a distinct phenotype in animals that has similarities to, and differences from, those of classic antidepressants and anxiolytics. CRAs are generally behaviorally silent, indicating that CRF1 receptors are normally in a state of low basal activation. CRAs reduce stressor-induced HPA axis activation by blocking pituitary and possibly brain CRF1 receptors which may ameliorate chronic stress-induced pathology. In animal models sensitive to anxiolytics and/or antidepressants, CRAs are generally more active in those with high stress levels, conditions which may maximize CRF1 receptor hyperactivation. Clinically, CRAs have demonstrated good tolerability and safety, but have thus far lacked compelling efficacy in major depressive disorder, generalized anxiety disorder, or irritable bowel syndrome. CRAs may be best suited for disorders in which stressors clearly contribute to the underlying pathology (e.g. posttraumatic stress disorder, early life trauma, withdrawal/abstinence from addictive substances), though much work is needed to explore these possibilities. An evolving literature exploring the genetic, developmental and environmental factors linking CRF1 receptor dysfunction to stress-related psychopathology is discussed in the context of improving the translational value of current animal models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiology and neurobiology of stress and adaptation: central role of the brain
McEwen, B. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00041.2006 · Cited by 5,429 · cited 1×
“A sizeable literature has indicated that chronic stress can have long term deleterious effects on the CNS which are mediated through excessive activation of the HPA axis (Sapolsky, 1999, 2000, 2001, 2003; McEwen, 2005, 2007, 2008).”
BackgroundMemory - A century of consolidation
McGaugh, J. L. (2000) · Science · doi:10.1126/science.287.5451.248 · Cited by 4,250
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“CRF (also known as corticotropin-releasing hormone, or CRH) is a 41 amino-acid peptide identified by Wylie Vale and colleagues three decades ago (Vale et al., 1981) that has been implicated in mediating an organism's behavioral, endocrine and autonomic responses to stress.”
BackgroundFears, phobias, and preparedness: toward an evolved module of fear and fear learning
Öhman, A., & Mineka, S. (2001) · Psychological Review · doi:10.1037/0033-295x.108.3.483 · Cited by 3,147 · cited 1×
“A major advantage of studying FC is that anxiety disorders in humans seem to involve alterations of fear processing circuits in the brain (Seligman, 1971;Marks, 1987; J. LeDoux, 1996; Lang et al., 2000; Ohman & Mineka, 2001; Charney, 2003; Pitman & Delahanty, 2005).”
BackgroundFear memories require protein synthesis in the amygdala for reconsolidation after retrieval
Nader, K., Schafe, G. E., & Le Doux, J. E. (2000) · Nature · doi:10.1038/35021052 · Cited by 2,706
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
McEwen, B. S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.071 · Cited by 1,864 · cited 9×
“But expression effects can be studied in isolation by using pre-long-term memory (LTM) test manipulations (as will be discussed later).”
BackgroundResultInfluentialSpecies-specific defense reactions and avoidance learning
Bolles, R. C. (1970) · Psychological Review · doi:10.1037/h0028589 · Cited by 1,610 · cited 1×
“The responses are usually hard-wired, speciestypical reactions that are themselves not learned (Bolles, 1970; R. J. Blanchard & Blanchard, 1971).”
BackgroundCharney, D. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.195 · Cited by 1,605
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485 · cited 2×
“…are reported to be elevated in at least some depressed patients (Nemeroff et al., 1984; Nemeroff, 1992) and a correlation to a blunted ACTH response to IV-administered CRF is cited as evidence suggestive of a coordinated hyperactivation of HPA and nonHPA axis CRF pathways (Newport et al., 2003).”
BackgroundGold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
CRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
Fear and anxiety: Animal models and human cognitive psychophysiology
Lang, P. J., Davis, M., & Öhman, A. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00343-8 · Cited by 1,162
Behavioral Inhibition: Linking Biology and Behavior within a Developmental Framework
Fox, N. A., Henderson, H. A., Marshall, P. J., Nichols, K. E., & Ghera, M. M. (2005) · Annual Review of Psychology · doi:10.1146/annurev.psych.55.090902.141532 · Cited by 1,040 · cited 1×
“Genetic studies have demonstrated an association with the CRF gene (Smoller et al., 2003; Smoller et al., 2005) and imaging studies indicate abnormal activity in the SRS (Stein, 1998; Schwartz et al., 2003; Fox et al., 2005).”
BackgroundAmat, J., Baratta, M. V., Paul, E., Bland, S. T., Watkins, L. R., & Maier, S. F. (2005) · Nature Neuroscience · doi:10.1038/nn1399 · Cited by 931
Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety
Walker, D. L., Toufexis, D. J., & Davis, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01282-2 · Cited by 838
Maier, S. F., & Watkins, L. R. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.021 · Cited by 737 · cited 1×
“In related studies, Steven Maier and colleagues have extensively examined the effects of acute escapable (ES) versus inescapable (IS) electrical shocks on subsequent shock-reinforced FC and other behaviors (for review see Maier & Watkins, 2005).”
BackgroundGlucocorticoids, depression, and mood disorders: Structural remodeling in the brain
McEwen, B. S. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.008 · Cited by 687
The Neuroscience of Mammalian Associative Learning
Fanselow, M. S., & Poulos, A. M. (2005) · Annual Review of Psychology · doi:10.1146/annurev.psych.56.091103.070213 · Cited by 683 · cited 1×
“Recent reviews summarizemajor findings about fear conditioning (J. E. LeDoux, 2000; Maren, 2001; D. L. Walker & Davis, 2002b; Rosen, 2004; M. S. Fanselow & Poulos, 2005) (see also Fig.”
Posttraumatic stress disorder: a state-of-the-science review
Nemeroff, C. B., Bremner, J. D., Foa, E. B., Mayberg, H. S., North, C. S., & Stein, M. B. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.07.005 · Cited by 675
Conrad, C. D., Magariños, A. M., LeDoux, J. E., & McEwen, B. S. (1999) · Behavioral Neuroscience · doi:10.1037/0735-7044.113.5.902 · Cited by 664
Corticotropin-releasing factor, norepinephrine, and stress
Koob, G. F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00164-x · Cited by 629 · cited 2×
“…the behavioral effects of direct intracerebral administration of CRF and related ligands and their interactions with CRF receptor antagonists (Koob, 1999; Pelleymounter et al., 2000; Heinrichs et al., 2002; Pelleymounter et al., 2002, 2004; Campbell et al., 2004; Zorrilla et al., 2004;…”
BackgroundSurget, A., Saxe, M., Leman, S., Ibarguen-Vargas, Y., Chalon, S., Griebel, G., Hen, R., & Belzung, C. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.02.022 · Cited by 556 · cited 2×
“In a Phase II study, oral pexacerfont (25 mg and 100 mg qd) was evaluated in a randomized, double-blind, placebo-controlled twoweek study for its effects on colonic transit and bowel function in female patients with diarrhea-predominant irritable bowel syndrome (D-IBS)(Sweetser et al., 2009).”
MethodPhillips, R. G., & LeDoux, J. E. (1994) · Learning & Memory · doi:10.1101/lm.1.1.34 · Cited by 528 · cited 1×
“A major advantage of studying FC is that anxiety disorders in humans seem to involve alterations of fear processing circuits in the brain (Seligman, 1971;Marks, 1987; J. LeDoux, 1996; Lang et al., 2000; Ohman & Mineka, 2001; Charney, 2003; Pitman & Delahanty, 2005).”
BackgroundHeim, C., Plotsky, P. M., & Nemeroff, C. B. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300397 · Cited by 514 · cited 1×
“Finally, adult depressives with a history of exposure to early life trauma demonstrate evidence for excessive HPA axis dysfunction (for reviews, see Heim et al., 2004; Nemeroff, 2004b).”
BackgroundGlucocorticoids, stress, and their adverse neurological effects: relevance to aging
Sapolsky, R. M. (1999) · Experimental Gerontology · doi:10.1016/s0531-5565(99)00047-9 · Cited by 507
A key role for corticotropin-releasing factor in alcohol dependence
Heilig, M., & Koob, G. F. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.006 · Cited by 503 · cited 2×
“Alcohol dependence has also been associated with hyperactivation of CRF1 receptors (for review, see Heilig & Koob, 2007).”
BackgroundSotres-Bayon, F., Cain, C. K., & LeDoux, J. E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.012 · Cited by 433
Self-citationRadulovic, J., Rühmann, A., Liepold, T., & Spiess, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05016.1999 · Cited by 402 · cited 1×
“Rau et al. (2005) conducted an extensive analysis of the interaction between a single footshock-stress session and fear conditioning.”
BackgroundThe CRF system, stress, depression and anxiety—insights from human genetic studies
Binder, E. B., & Nemeroff, C. B. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.141 · Cited by 379
Defense system psychopharmacology: An ethological approach to the pharmacology of fear and anxiety
Blanchard, R. J., Yudko, E. B., Rodgers, R. J., & Blanchard, D. C. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90100-5 · Cited by 367
Fanselow, M. S. (1986) · Learning and Motivation · doi:10.1016/0023-9690(86)90018-4 · Cited by 326 · cited 1×
“Second, ‘shock-elicited freezing’ does not even occur in the shock context unless the rats have sufficient time before the shocks to compile a configural representation of the context CS (e.g. immediate shock deficit; Blanchard et al., 1976; Fanselow, 1986, 1990).”
BackgroundSommer, W. H., Rimondini, R., Hansson, A. C., Hipskind, P. A., Gehlert, D. R., Barr, C. S., & Heilig, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.010 · Cited by 309 · cited 1×
“…elevated NE levels has also been reported in PTSD (for review, see Kasckow et al., 2001) and pharmacological activation with yohimbine was reported to evoke PTSD symptoms (Southwick et al., 1999; Bremner, 2006), HPA axis activation, and increases in CRF and NE in the CSF (Vythilingam et al., 2000).”
BackgroundSagami, Y., Shimada, Y., Tayama, J., Nomura, T., Satake, M., Endo, Y., Shoji, T., Karahashi, K., Hongo, M., & Fukudo, S. (2004) · Gut · doi:10.1136/gut.2003.018911 · Cited by 291 · cited 1×
“…to painful peripheral gut stimulation (Mayer et al., 2005) and IV infusion of a non-selective peptidic CRF1/2 receptor antagonist, α-helical-CRF, produced improvements in gut stimulation-induced changes in gastrointestinal motility, visceral pain perception, and negative mood (Sagami et al., 2004).”
BackgroundSarnyai, Z., Bíró, É., Gardi, J., Vecsernyés, M., Julesz, J., & Telegdy, G. (1995) · Brain Research · doi:10.1016/0006-8993(95)00043-p · Cited by 255 · cited 1×
“…drugs of abuse, such as cocaine, amphetamine, and morphine have been associated with heightened CRF release (Sarnyai et al., 1995; Sarnyai, 1998; Sarnyai et al., 2001), ndocrine, and autonomic components which act in concert to generate an appropriate, eptor, which is normally in a low state of…”
BackgroundBinneman, B., Feltner, D., Kolluri, S., Shi, Y., Qiu, R., & Stiger, T. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071199 · Cited by 254
Deak, T., Nguyen, K. T., Ehrlich, A. L., Watkins, L. R., Spencer, R. L., Maier, S. F., Licinio, J., Wong, M.-L., Chrousos, G. P., Webster, E., et al. (1999) · Endocrinology · doi:10.1210/endo.140.1.6415 · Cited by 242
Walker, D. L., & Davis, M. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0183-3 · Cited by 231 · cited 1×
“Walker and Davis have described an unconditioned fear test using the startle response as a behavioral endpoint which appears to be sensitive to CRAs (D. L. Walker et al., 2003; D. L. Walker & Davis, 2002a, 2008).”
MethodRosen, J. B. (2004) · Behavioral and Cognitive Neuroscience Reviews · doi:10.1177/1534582304265945 · Cited by 219 · cited 1×
“Recent reviews summarizemajor findings about fear conditioning (J. E. LeDoux, 2000; Maren, 2001; D. L. Walker & Davis, 2002b; Rosen, 2004; M. S. Fanselow & Poulos, 2005) (see also Fig.”
Moriceau, S., Shionoya, K., Jakubs, K., & Sullivan, R. M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4106-09.2009 · Cited by 214
Deębiec, J., Doyère, V., Nader, K., & LeDoux, J. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507168103 · Cited by 207
Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist
Mansbach, R. S., Brooks, E. N., & Chen, Y. L. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00025-3 · Cited by 195 · cited 21×
“Cain / Pharm acology & Therapeutics 128 (2010) 460 –487 Table 2 (continued) Therapeutic application/System Assay (endpoint, special test conditions, strains, etc.) Species Active CRAs Inactive CRAs Anxiety Social interaction, Flinders sensitive line Rat CP-154,526 (chronic, 14 days) (Overstreet, Keeney et al., 2004) S…”
BackgroundMethodResultInfluentialTreutlein, J., Kissling, C., Frank, J., Wiemann, S., Dong, L., Depner, M., Saam, C., Lascorz, J., Soyka, M., Preuss, U. W., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001813 · Cited by 186 · cited 1×
“…elevated NE activity produced by administration of the α2-adrenergic antagonist yohimbine (Vythilingam et al., 2000) or decreased 5HT activity resulting from administration of a “5HT-depleting” diet (Tyrka et al., 2004) is reported to result in an elevation of CRF levels in the CSF in humans.”
BackgroundPharmacological treatments that facilitate extinction of fear: Relevance to psychotherapy
Davis, M., Myers, K. M., Chhatwal, J., & Ressler, K. J. (2006) · NeuroRX · doi:10.1016/j.nurx.2005.12.008 · Cited by 174 · cited 1×
“In addition, new breakthroughs in pharmacological approaches to overcoming phobias by enhancing extinction processes (Davis et al., 2006; Davis et al., 2007) or ameliorating intrusive negative memories by interfering with memory reconsolidation (Nader et al.”
BackgroundBakshi, V. P., Smith-Roe, S., Newman, S. M., Grigoriadis, D. E., & Kalin, N. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02926.2002 · Cited by 171
Austin, M. C., Janosky, J. E., & Murphy, H. A. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001250 · Cited by 162 · cited 1×
“…of the brains of depressed suicide victims have also demonstrated elevated CRF immunoreactivity in specific brainstem monoaminergic nuclei, including NE cells of the locus coeruleus (Bissette et al., 2003; Merali et al., 2006) and 5HT cells of the dorsal raphe (Nemeroff, 2002; Austin et al., 2003).”
BackgroundSautter, F. J., Bissette, G., Wiley, J., Manguno-Mire, G., Schoenbachler, B., Myers, L., Johnson, J. E., Cerbone, A., & Malaspina, D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00571-7 · Cited by 162
Baratta, M. V., Christianson, J. P., Gomez, D. M., Zarza, C. M., Amat, J., Masini, C. V., Watkins, L. R., & Maier, S. F. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.042 · Cited by 156 · cited 2×
“This effect occurs when rats receive IS either 1-week or 1-day prior to context FC (Amat et al., 2005; Baratta et al., 2007).”
BackgroundStinus, L., Cador, M., Zorrilla, E. P., & Koob, G. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300487 · Cited by 139 · cited 12×
“The authors have argued that the BNST mediates more prolonged, sustained states of anxiety.”
BackgroundInfluentialElevated Concentrations of CRF in the Locus Coeruleus of Depressed Subjects
Bissette, G., Klimek, V., Pan, J., Stockmeier, C., & Ordway, G. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300191 · Cited by 136
Hammack, S. E., Richey, K. J., Watkins, L. R., & Maier, S. F. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.2.443 · Cited by 130 · cited 13×
“The authors have argued that the BNST mediates more prolonged, sustained states of anxiety.”
BackgroundInfluentialSB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats
Knapp, D. J., Overstreet, D. H., Moy, S. S., & Breese, G. R. (2004) · Alcohol · doi:10.1016/j.alcohol.2003.08.007 · Cited by 130 · cited 6×
“Cain / Pharm acology & Therapeutics 128 (2010) 460 –487 Table 2 (continued) Therapeutic application/System Assay (endpoint, special test conditions, strains, etc.) Species Active CRAs Inactive CRAs Anxiety Social interaction, Flinders sensitive line Rat CP-154,526 (chronic, 14 days) (Overstreet, Keeney et al., 2004) S…”
BackgroundInfluentialEnvironmental control of defensive reactions to footshock
Blanchard, R. J., Fukunaga, K. K., & Blanchard, D. C. (1976) · Bulletin of the Psychonomic Society · doi:10.3758/bf03335103 · Cited by 106
Light-enhanced startle: further pharmacological and behavioral characterization
Walker, D. L., & Davis, M. (2002) · Psychopharmacology · doi:10.1007/s002130100913 · Cited by 101
Stout, S. C., Mortas, P., Owens, M. J., Nemeroff, C. B., & Moreau, J.-L. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00412-x · Cited by 94 · cited 1×
“Hyperactivation of CRF1 pathways have been implicated in panic disorder (for review, see Strohle & Holsboer, 2003) though evidence is mixed that the HPA axis is dysfunctional in patients withpanic disorder (e.g. (Kellner et al., 2004).”
BackgroundFossey, M. D., Lydiard, R. B., Ballenger, J. C., Laraia, M. T., Bissette, G., & Nemeroff, C. B. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00197-2 · Cited by 90
Walker, D., Yang, Y., Ratti, E., Corsi, M., Trist, D., & Davis, M. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.210 · Cited by 69 · cited 1×
“‘Stress’ is perhaps the most broadly defined category and can refer to any bodily response to threatening demand (Selye, 1975) including endocrine responses and fearful/anxious behavioral responses (Weninger et al., 1999).”
BackgroundBaratta, M. V., Lucero, T. R., Amat, J., Watkins, L. R., & Maier, S. F. (2008) · Learning & Memory · doi:10.1101/lm.800308 · Cited by 58 · cited 1×
“Interestingly, the critical variable in these studies appears to be control, as ES rats actually show suppressed conditioned freezing compared to homecage controls (Baratta et al., 2007; Baratta et al., 2008).”
Backgroundde Jongh, R., Groenink, L., van der Gugten, J., & Olivier, B. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00468-2 · Cited by 54 · cited 1×
“The terms stress, fear and anxiety are used interchangeably but are also used to denote different reactions to aversive stimulation (R. J. Blanchard et al., 1993; Charney & Deutch, 1996; Davis et al., 1997b; de Jongh et al., 2003; Todorovic et al., 2007).”
BackgroundCRF1 and CRF2 Receptors are Required for Potentiated Startle to Contextual but not Discrete Cues
Risbrough, V. B., Geyer, M. A., Hauger, R. L., Coste, S., Stenzel-Poore, M., Wurst, W., & Holsboer, F. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.205 · Cited by 49 · cited 6×
“Cain / Pharm acology & Therapeutics 128 (2010) 460 –487 Table 2 (continued) Therapeutic application/System Assay (endpoint, special test conditions, strains, etc.) Species Active CRAs Inactive CRAs Anxiety Social interaction, Flinders sensitive line Rat CP-154,526 (chronic, 14 days) (Overstreet, Keeney et al., 2004) S…”
BackgroundInfluentialSuppression of Conditioned Fear by Administration of CRF Receptor Antagonist CP-154,526
Hikichi, T., Akiyoshi, J., Yamamoto, Y., Tsutsumi, T., & Isogawa, K. (2000) · Pharmacopsychiatry · doi:10.1055/s-2000-7587 · Cited by 47
Lydiard, R. B. (2005) · CNS Spectrums · doi:10.1017/s1092852900019878 · Cited by 45 · cited 3×
“A disorder that is frequently comorbid with anxiety (Lydiard, 2001, 2005) is irritable bowel syndrome (IBS), a stress-related gastrointestinal disorder characterized by disturbed bowel habits (diarrhea and/or constipation) and visceral abdominal pain (Lydiard, 2005).”
BackgroundAlcoholism, corticotropin-releasing factor, and molecular genetic allostasis
Koob, G. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.005 · Cited by 14
Cited by
Adaptation and validation of the depression, anxiety and stress scale (DASS) to Brazilian Portuguese
Vignola, R. C. B., & Tucci, A. M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.10.031 · Cited by 887
“In addiction, stress has been demonstrated to be a risk factor for the development of anxiety and depression, affecting quality of life and hampering productivity (Kehne, 2007; Kehne and Cain, 2010).”
BackgroundAltering the course of schizophrenia: progress and perspectives
Millan, M. J., Andrieux, A., Bartzokis, G., Cadenhead, K., Dazzan, P., Fusar-Poli, P., Gallinat, J., Giedd, J., Grayson, D. R., Heinrichs, M., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.28 · Cited by 516
Role of neuropeptides in anxiety, stress, and depression: From animals to humans
Kormos, V., & Gaszner, B. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.014 · Cited by 329
Burke, A. R., McCormick, C. M., Pellis, S. M., & Lukkes, J. L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.018 · Cited by 225
Brain and gut CRF signaling: biological actions and role in the gastrointestinal tract
Tache, Y., Larauche, M., Yuan, P.-Q., & Million, M. (2018) · Current Molecular Pharmacology · doi:10.2174/1874467210666170224095741 · Cited by 147
“Among those, NBI-30545, NBI-35965, NGD 98–2 and NGD 9002 have the distinct advantage to be orally active and water-soluble [17, 132, 290, 291].”
Background
Metadata
- Authors
- Kehne, J. H., & Cain, C. K.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 128
- Issue
- 3
- Pages
- 460-487
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1999397021
- Cited by
- 105
- References
- 63
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.